![]() "The French national reimbursement decision is an important step in providing broader access to people with diabetes, and we are working with other countries to extend this coverage to more people." "Our goal is to get our FreeStyle Libre technology to as many people as possible," said Jared Watkin, senior vice president of Abbott's diabetes care business. Together, this represents 3 million more people living with diabetes who are now eligible to use FreeStyle Libre technology to manage their condition. This follows similar reimbursement coverage expansions for its technology in Japan and the U.S. The expanded reimbursement enables more people living with diabetes in France 1 to access the latest CGM technology that can help them make informed health and lifestyle decisions.įrance is the first country in Europe to expand national reimbursement of Abbott's world-leading FreeStyle Libre technology to people with diabetes who use basal insulin. ![]() More than 90% of people living with diabetes in France have Type 2 diabetes, which can lead, in the absence of appropriate care, to serious complications affecting the heart, blood vessels, eyes, kidneys and nervous system. ![]() ![]() FreeStyle Libre 2 was previously covered only for people with Type 1 and Type 2 diabetes who require intensive insulin therapy. (Medicare)ĪBBOTT PARK, Ill., J/PRNewswire/ - Abbott (NYSE: ABT) today announced that the French health authority has approved the expansion of reimbursement coverage for its FreeStyle Libre 2 system to include all people who use basal insulin as part of their diabetes management. First and only continuous glucose monitoring system to be nationally reimbursed in France for people who use once-daily (basal) insulin 1Įxpanded reimbursement facilitates wider access to continuous glucose monitoring (CGM) systems, serving a greater population of people living with diabetesįrance is the first country in Europe to grant national reimbursement for people who use basal insulin, following similar reimbursement expansions in Japan and the U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |